Livealth Biopharma Private Limited

Deferoxamine Mesylate Injection is a medication mainly used to remove excess iron or aluminum from the body. It works by binding (chelating) these metals so they can be excreted in urine or bile.

Used in patients who have too much iron in the body, such as:

• Thalassemia major

• Sickle cell disease

• Patients receiving frequent blood transfusions

• Acute iron poisoning (especially in children)

• In patients with chronic kidney disease, especially those on dialysis

• Removes excess aluminum that can cause bone disease or neurological problems

• Injection: intravenous (IV), intramuscular (IM), or subcutaneous (SC)

• Dose depends on the condition and patient’s iron levels

• Pain or swelling at injection site

• Nausea, vomiting

• Low blood pressure (with rapid IV use)

• Visual or hearing disturbances (with long-term use)

• Requires regular monitoring of iron levels

• Long-term use should be supervised by a healthcare professional

• Not effective for iron deficiency anemia